|
ZFAND5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.023500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.978300E-02 |
| Normal-vs-Stage2 |
6.234200E-01 |
| Normal-vs-Stage3 |
2.175600E-01 |
| Normal-vs-Stage4 |
5.712000E-01 |
| Stage1-vs-Stage2 |
3.790000E-02 |
| Stage1-vs-Stage3 |
2.185800E-01 |
| Stage1-vs-Stage4 |
1.872620E-01 |
| Stage2-vs-Stage3 |
4.778600E-01 |
| Stage2-vs-Stage4 |
8.334000E-01 |
| Stage3-vs-Stage4 |
6.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.291900E-02 |
| Normal-vs-AfricanAmerican |
7.982200E-02 |
| Normal-vs-Asian |
1.910630E-01 |
| Caucasian-vs-AfricanAmerican |
6.858000E-01 |
| Caucasian-vs-Asian |
3.392400E-01 |
| AfricanAmerican-vs-Asian |
4.639000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.431600E-02 |
| Normal-vs-Female |
3.061000E-01 |
| Male-vs-Female |
7.962000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.006400E-01 |
| Normal-vs-Extreme_Weight |
2.758300E-02 |
| Normal-vs-Obese |
3.903200E-01 |
| Normal-vs-Extreme_Obese |
2.918400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.624380E-01 |
| Normal_Weight-vs-Obese |
5.063800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.475200E-01 |
| Extreme_Weight-vs-Obese |
2.618400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.731000E-01 |
| Obese-vs-Extreme_Obese |
5.111000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.441600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.136800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.905800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.268300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.586400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.694300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.226840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.576120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.960400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.957000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.218300E-02 |
| Normal-VS-Type2 PRCC |
3.537800E-02 |
| Normal-VS-KIRP CIMP |
8.037900E-02 |
| Normal-VS-Unclassified PRCC |
1.795800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.711000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.45870000043547E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.322600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.51570000000079E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.776000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.165100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.363600E-02 |
| Normal-vs-N1 |
5.308400E-01 |
| Normal-vs-N2 |
7.187000E-01 |
| N0-vs-N1 |
1.890590E-01 |
| N0-vs-N2 |
1.463840E-01 |
| N1-vs-N2 |
3.219600E-01 |
|
|
